Company intelligence / Profile preview

Industrial Microbes

Ownership: Private
Development stage: Preclinical

Overview

Industrial Microbes has demonstrated successful scale-up of its proprietary microbial fermentation processes to produce bio-based acrylic acid precursors and other chemicals from renewable feedstocks like ethanol and methane. The company holds 22 patents, has raised over $10M in funding, and collaborates with commercial partners to bring sustainable materials to market. No clinical results as the focus is on industrial applications.

Therapeutic areas: Other
Modalities: Microbial therapy/Biomanufacturing process
Industry: Non-Drug Biotech

Partnerships

Agile BioFoundry collaboration for machine learning optimization in gas fermentationFour unnamed commercial partners for co-development/scale-up projects

Beyond the preview

Go deeper on Industrial Microbes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Industrial Microbes.

Explore the full profile